SignalXSignalX

SELECT MEDICAL HOLDINGS CORP (SEM) 8-K Current Report: March 3, 2026

Filed: March 3, 2026
Health Care
Services-Hospitals
SELECT MEDICAL HOLDINGS CORP Overview

SELECT MEDICAL HOLDINGS CORP (SEM) 8-K current report filed with SEC EDGAR on March 3, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
2 items

  • Item 1.01: Entry into a Material Definitive Agreement
  • Item 7.01: Regulation FD Disclosure

SELECT MEDICAL HOLDINGS CORP 8-K Mar 3, 2026 Event Analysis

Item 1.01 · Entry into a Material Definitive Agreement

  • • Merger Consideration: $16.50/share cash — SEM shareholders receive fixed takeout price, shares to be delisted from NYSE upon close
  • • Buyer is Stallion Intermediate Corp, financed by private equity firm WCAS XIV, L.P. (Welsh, Carson, Anderson & Stowe) via equity + debt commitment letters
  • • Deal requires majority vote of unaffiliated shareholders (excluding Rollover Holders/Parent affiliates) — double approval threshold raises execution risk slightly
  • • Termination fees asymmetric: SEM pays $66.5M if it walks for superior proposal; Parent pays $133.0M if it fails to close — ~2x reverse breakup fee signals buyer commitment
  • • Outside date December 1, 2026 (extendable to March 1, 2027); conditions include HSR antitrust clearance and healthcare regulatory approvals

Item 7.01 · Regulation FD Disclosure

  • • SEM undergoing proposed go-private acquisition — company filing Schedule 14A proxy and Schedule 13E-3, signaling a take-private or buyout structure
  • • Stockholder vote required to approve merger — failure to obtain approval is an explicit deal-closing risk
  • • Termination fee payable by SEM under certain conditions if merger is abandoned — potential cash cost to shareholders if deal falls through
  • • "Rollover Holders" identified as solicitation participants — insiders rolling equity into new entity, interests may diverge from public shareholders
  • • Stock price decline risk explicitly flagged if merger is not consummated — downside scenario for investors holding SEM anticipating deal close

Get deeper insights on SELECT MEDICAL HOLDINGS CORP

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.